SteadyMed, Ltd., a company that develops products to treat orphan and high-value conditions with unmet parenteral delivery needs, recently announced that its lead product candidate, Trevyent® has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH).
Reata Pharmaceuticals, Inc., recently announced the enrollment of the first patient with pulmonary hypertension associated with interstitial lung disease (PH-ILD) in its LARIAT study, a Phase 2 clinical trial assessing the safety, efficacy, and tolerability of bardoxolone methyl in patients with pulmonary hypertension (PH). PH is characterized by unusually high…
Team PHenomenal Hope will take part in a seven-day cycling competition to raise awareness of pulmonary hypertension (PH) and money to advance research into the disease. The nonprofit, presented by the University of Pittsburgh Medical Center (UPMC), Bayer Healthcare, and Actelion, is competing in the The Pioneer race through New Zealand’s Southern Alps.
Pulmonary Hypertension News has covered news surrounding the latest treatments, events, clinical trials, and research updates related to pulmonary hypertension on a daily basis throughout the past year. As the year of 2015 comes to an end, our “Top 10 Most Read Pulmonary Hypertension Articles of 2015” ranks the…
Boehringer Ingelheim recently announced the enrollment of the first patient in its global, double-blind, randomized, and placebo-controlled SENSCIS (Safety and Efficacy of Nintedanib in Systemic SClerosIS) Phase 3 clinical trial. The trial (NCT02597933) is now enrolling patients, and is evaluating the safety and the efficacy of nintedanib in patients with systemic sclerosis (SSc)…
German President Joachim Gauck has awarded the 2015 Deutscher Zukunftspreis, which honors innovation in science and technology, to a pulmonary hypertension (PH) research team that discovered and developed a drug effective in the treatment of two serious types of the disease. The winning team — led by Professor Ardeschir Ghofrani from the University Clinic…
Eiger BioPharmaceuticals, Inc. recently announced in a press release that a Notice of Allowance from the United States Patent and Trademark Office (USPTO) has been issued for the U.S. patent application 13/829,321, titled “Treatment of Pulmonary Hypertension with Leukotriene Inhibitors” covering Bestatin™ (ubenimex), a leukotriene A4hydrolase (LTA4H) inhibitor, for treating…
The Sacramento Santa Run, now in its third year, is holding a 5k Run/Walk and a Merry Mile event on Saturday, Dec. 19, to benefit the California Chapter of the Pulmonary Hypertension Association (PHA). The full-day charity event opens at 7 a.m. with race registration and the run/walk itself, beginning at the State…
The Pulmonary Hypertension Association’s International PH Conference and Scientific Sessions is one of the largest gatherings on pulmonary hypertension (PH) worldwide, bringing patients, caregivers and top healthcare professionals together to share stories, exchange information, and network. Planning for the 2016 conference, to take place in Dallas, Texas, from June 17-19, is getting underway, and…
The California Chapter of the Pulmonary Hypertension Association will host its Second Annual Long Beach O2 breathe Walk in Long Beach, California, on Saturday, Nov. 14, at 9 a.m. PT at El Dorado Regional Park. The event, dubbed the O2 breathe Walk, is a fundraising campaign that gathers together families, friends…
November is Pulmonary Hypertension Awareness Month and the Pulmonary Hypertension Association (PHA) is planning to launch a new public service campaign called Heart2CurePH that promises to increase understanding of pulmonary hypertension (PH). The worldwide educational campaign will include TV, radio, and place-based and print materials, while anyone on social media can…
The latest comic book in a peer-reviewed series on pulmonary hypertension (PH) has been launched by Medikis, with the collaboration of the Imperial College Healthcare NHS Trust. The comic book, entitled Medikidz Explains Pulmonary Arterial Hypertension, aims to increase knowledge about the life-threatening disease among younger audiences.
Get regular updates to your inbox.